Replies to post #386004 on Amarin Corp Plc (AMRN)

[sstyles]

I searched the net and found this from Terrapharma:

🔍In addition to those two patents granted, partner Mochida has filed a patent application for "REDUCING NEW ONSET DIABETES" using icosapentaenoic acid and statin. 🔥🔥🔥 $AMRN #collaboration #partners pic.twitter.com/xXl3dxv3QN

— TerraPharma (@TerraPharma1) December 3, 2019

(scroll down)

https://pbs.twimg.com/media/EK5I3X2UYAA3din?format=jpg&name=4096x4096

Even if generics tried to challenge the patent, I imagine we would have a marketing advantage....why take 4 pills when one a day suffices..

Older interesting article:
https://www.ajmc.com/view/a636-article